SCHEMBL21035265

SCHEMBL21035265

c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5c(c4)c4ccccc4c4c6ccccc6c6ccccc6c54)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
ATM Q13315 2/20 0.48
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
IL1R1 P14778 1/20 0.38
TSPO P30536 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
NR4A2 P43354 2/20 0.37
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
AVPR1A P37288 1/20 0.36
HDAC4 P56524 1/20 0.35
PTGER4 P35408 1/20 0.33
PIM1 P11309 1/20 0.33
FAAH O00519 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034923 0.97 L3MBTL1 (0.55) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21034876 0.97 L3MBTL1 (0.55) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21035228 0.97 L3MBTL1 (0.44) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21034925 0.95 L3MBTL1 (0.56) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21035229 0.94 L3MBTL1 (0.50) L3MBTL1ATMKDM4EKMT2AIL1R1
SCHEMBL21034875 0.94 L3MBTL1 (0.58) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21034874 0.94 L3MBTL1 (0.58) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL10130170 0.93 L3MBTL1 (0.55) L3MBTL1ATMKDM4EKMT2AMAPK1
SCHEMBL21034917 0.92 KDM4E (0.39) L3MBTL1ATMKDM4EKMT2AIL1R1
SCHEMBL16133211 0.92 L3MBTL1 (0.56) L3MBTL1ATMKDM4EKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 L3MBTL1 834/4885ATM 1673/4885KDM4E 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.